Cargando…
Low-Salt Diet Reduces Anti-CTLA4 Mediated Systemic Immune-Related Adverse Events while Retaining Therapeutic Efficacy against Breast Cancer
SIMPLE SUMMARY: Immunotherapy has transformed breast cancer treatment. However, ICI-induced systemic inflammatory immune-related adverse events (irAE) remain a major clinical challenge. In our current communication, using breast tumor models, we demonstrated that a low salt diet could reduce irAE de...
Autores principales: | Khandekar, Durga, Dahunsi, Debolanle O., Manzanera Esteve, Isaac V., Reid, Sonya, Rathmell, Jeffrey C., Titze, Jens, Tiriveedhi, Venkataswarup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219826/ https://www.ncbi.nlm.nih.gov/pubmed/35741331 http://dx.doi.org/10.3390/biology11060810 |
Ejemplares similares
-
Role of BET Inhibitors in Triple Negative Breast Cancers
por: Khandekar, Durga, et al.
Publicado: (2020) -
Ex Vivo High Salt Activated Tumor-Primed CD4+T Lymphocytes Exert a Potent Anti-Cancer Response
por: Tiriveedhi, Venkataswarup, et al.
Publicado: (2021) -
Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
por: Khandekar, Durga, et al.
Publicado: (2019) -
Cancer Salt Nostalgia
por: Allu, Aashish S., et al.
Publicado: (2021) -
High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx
por: Babaer, Duaa, et al.
Publicado: (2018)